Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2024-09-25 Regulatory Filings
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document announces a strategic agreement between two medical technology companies, elliquence and Implanet, regarding US distribution rights for a specific product (Ultrasonic Bone Scalpel Olea). It details the partnership, includes quotes from executives, and provides background information on both companies. This type of announcement, detailing a significant business development or agreement, does not fit neatly into standard periodic financial reports (10-K, IR, ER) or specific corporate actions like dividends or director dealings. It is a general business update or press release concerning strategic operations. Since there is no specific category for 'Strategic Partnership Announcement' and it is not a formal regulatory filing like a 10-K or a report announcement (RPA), the most appropriate fallback category is Regulatory Filings (RNS) for general corporate news that doesn't fit elsewhere, although it strongly resembles a press release.
2024-09-25 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document announces a strategic partnership agreement between two medical technology companies, elliquence LLC and Implanet, for the exclusive distribution of Implanet's Olea ultrasonic bone scalpel in the US spine surgery market. It details the synergy of their products and includes quotes from management regarding the strategic implications. This type of announcement, focusing on a significant business development, partnership, or strategic move that is not a standard periodic financial report (like 10-K or IR) or a specific transaction (like M&A or share repurchase), fits best under a general business/regulatory announcement category. Since it is a press release announcing a major business development rather than a formal regulatory filing like a 10-K or a specific financial event like a dividend or capital change, and it doesn't fit the definitions for CT, ER, or LTR, the most appropriate classification is Regulatory Filings (RNS) as a general announcement, or potentially a general press release that falls under this broad category if a more specific 'Press Release' code is unavailable. Given the provided options, RNS serves as the best fit for a significant, non-standard corporate announcement.
2024-09-25 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release dated September 19, 2024, announcing that IMPLANET will co-exhibit at the NASS meeting. It details the technologies they will showcase (Olea, spinal implants) alongside 8i Robotics. Crucially, it includes a section titled "Upcoming financial event: • 2024 third-quarter revenue on October 8, 2024, after market close". This structure—a general business update combined with an announcement of an upcoming financial event—is characteristic of a general press release or regulatory filing that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a general announcement about business activities and future reporting dates, and not a formal financial statement, an earnings release, or a management discussion, the most appropriate general category is Regulatory Filings (RNS), as it serves as a broad disclosure mechanism.
2024-09-19 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release dated September 19, 2024, announcing that IMPLANET will exhibit alongside 8i Robotics at the NASS conference. It details the products to be presented (Olea osteotome, spinal implants) and includes quotes from management. Crucially, it contains a section titled "Prochain communiqué financier" (Next financial release) which explicitly states: "Chiffre d'affaires du 3ème trimestre 2024, le 8 octobre 2024 après bourse" (Third quarter 2024 revenue, October 8, 2024 after market close). This structure—a general business update combined with a forward-looking announcement of a specific financial report release date—is characteristic of a general press release or regulatory announcement that doesn't fit the specific definitions of an Earnings Release (ER, which would contain the actual results) or an Interim Report (IR, which would contain the full financials). Since it is a general announcement about business activities and future reporting, and it is not a formal regulatory filing like a 10-K or a specific report type, the most appropriate classification is Regulatory Filings (RNS) as a general announcement, or potentially a Report Publication Announcement (RPA) if the primary focus was announcing the upcoming Q3 report, but the primary content here is the trade show participation. Given the mix, RNS serves as the best general regulatory announcement category for non-standard press releases.
2024-09-19 French
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Interim / Quarterly Report Classification · 1% confidence The document is a 'Rapport Financier Semestriel' (Interim Financial Report) for the period ending June 30, 2024. It contains comprehensive financial statements, including the balance sheet, income statement, cash flow statement, and management discussion and analysis (Rapport d'activité). It is a full report, not an announcement or a summary, and it provides substantive financial data for a period shorter than a full fiscal year. H1 2024
2024-09-16 French
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel
Report Publication Announcement Classification · 1% confidence The document is a short press release (2594 characters) dated September 16, 2024, titled "IMPLANET met à disposition son rapport financier semestriel 2024" (IMPLANET makes available its 2024 half-year financial report). The text explicitly states that the 'rapport financier semestriel au 30 juin 2024' (half-year financial report as of June 30, 2024) is now available and provides links where it can be accessed (company website and AMF). This structure—a brief announcement stating a report has been published and directing the reader elsewhere—perfectly matches the definition of a Report Publication Announcement (RPA). It is not the comprehensive report itself (which would be an IR or 10-K), nor is it an Earnings Release (ER) which typically contains key figures, although it mentions the next earnings release date.
2024-09-16 French

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.